Get the Stockscreener App
1.45
1.36%
-0.02
After Hours:
1.76
0.31
+21.38%
Biocardia Inc stock is traded at $1.45, with a volume of 37,072.
It is down -1.36% in the last 24 hours and up +11.54% over the past month.
BioCardia Inc is a clinical-stage company developing cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases with unmet medical needs. Its two cell therapy platforms derived from the bone marrow. CardiAMP autologous mononuclear cell therapy platform is being advanced for two clinical indications: ischemic heart failure with reduced ejection fraction (HFrEF) and refractory angina resulting from chronic myocardial ischemia (CMI). Its immunomodulatory allogeneic mesenchymal stem cell (MSC) therapy platform is being an off the shelf cell therapy for two clinical indications: the treatment of ischemic HFrEF (CardiALLO), which is actively enrolling, and acute respiratory distress syndrome (ARDS).
See More
Previous Close:
$1.47
Open:
$1.4712
24h Volume:
37,072
Relative Volume:
0.07
Market Cap:
$15.39M
Revenue:
$3,000
Net Income/Loss:
$-8.79M
P/E Ratio:
-0.6894
EPS:
-2.1033
Net Cash Flow:
$-8.46M
1W Performance:
+5.84%
1M Performance:
+11.54%
6M Performance:
-34.09%
1Y Performance:
-33.18%
1-Day Range:
$1.4101
$1.48
1-Week Range:
$1.40
$1.50
52-Week Range:
$1.00
$3.20
Biocardia Inc Stock (BCDA) Company Profile
Name
Biocardia Inc
Sector
Industry
Phone
650-226-0123
Address
320 SOQUEL WAY, SUNNYVALE, CA
Compare BCDA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
| 0.41 | 0 | 0 | 0 | 0 | 0.00 | |
GOODO
Gladstone Commercial Corporation
|
20.66 | 372.90M | 0 | 0 | 0 | 0.00 |
|
PSNYW
Polestar Automotive Holding Uk
|
4.30 | 268.44M | 2.07B | -1.42B | -1.37B | -0.6765 |
|
SHMD
Schmid Group N V
|
5.14 | 223.06M | 0 | 0 | 0 | 0.00 |
|
DAVEW
Dave Inc
|
0.7287 | 0 | 0 | 0 | 0 | 0.00 |
|
DWLD
Davis Select Worldwide ETF
|
46.74 | 0 | 0 | 0 | 0 | 0.00 |
Biocardia Inc Stock (BCDA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-16-21 | Downgrade | Dawson James | Buy → Neutral |
Biocardia Inc Stock (BCDA) Latest News
US Market Wrap: How Akso Health Group Depositary Receipt stock compares to industry benchmarksMarket Trend Review & Proven Capital Preservation Tips - moha.gov.vn
Revenue Check: Why BioCardia Inc 6JU0 stock stays undervalued2025 Dividend Review & High Win Rate Trade Tips - moha.gov.vn
BioCardia (NASDAQ:BCDA) Trading Up 4.4% – Here’s Why - Defense World
Can BioCardia Inc. (6JU0) stock surprise markets with earningsStop Loss & Verified Momentum Stock Watchlist - Newser
What MACD trends signal for BioCardia Inc. (6JU0) stockRate Hike & Scalable Portfolio Growth Ideas - Newser
Why institutional investors increase stakes in BioCardia Inc. (6JU0) stockJuly 2025 Market Mood & Momentum Based Trading Ideas - Newser
Will BioCardia Inc. (6JU0) stock outperform benchmarksMarket Trend Summary & AI Forecast Swing Trade Picks - Newser
How strong dollar benefits BioCardia Inc. (6JU0) stockJuly 2025 Fed Impact & AI Based Buy and Sell Signals - Newser
BioCardia appoints Marvin Slosman to board as Richard Krasno departs By Investing.com - Investing.com Canada
BioCardia Announces Election of New Board Director, Marvin Slosman and Completion of Term for Outgoing Director, Dr. Richard Krasno - The Globe and Mail
BioCardia Appoints Marvin Slosman to Board of Directors - MSN
Biocardia announces election of new board director - marketscreener.com
BioCardia (NASDAQ: BCDA) elects Marvin Slosman to board, honors Dr. Krasno - Stock Titan
Why BioCardia Inc. (6JU0) stock stays resilientJuly 2025 PostEarnings & Community Consensus Trade Alerts - Newser
Is BioCardia Inc. (6JU0) stock a top pick for value investorsBull Run & Fast Momentum Entry Tips - Newser
BioCardia to Present at December 2025 CSI Focus Devices in Heart Failure Congress - The Manila Times
BioCardia to Present at CSI Focus Devices in Heart Failure Conference in Frankfurt - Quiver Quantitative
BioCardia (NASDAQ: BCDA) to Discuss Heart Failure Cell Therapy at CSI Focus D-HF - Stock Titan
Is Sanghvi Movers Limited Positioned to Benefit From Secular ShiftsTechnical Pattern Recognition & Weekly Consultation With Financial Pros - earlytimes.in
Is BioCardia Inc 6JU0 a good long term investmentStraddle and Strangle Trades & High Return Capital Gains - earlytimes.in
Why BioCardia Inc. stock remains on buy listsQuarterly Trade Report & Daily Profit Focused Stock Screening - BỘ NỘI VỤ
Can BioCardia Inc. stock deliver surprise earnings beatWeekly Profit Analysis & Technical Pattern Based Buy Signals - moha.gov.vn
Is BioCardia Inc. stock attractive for ETFsJuly 2025 Macro Moves & Weekly Hot Stock Watchlists - moha.gov.vn
Is BioCardia Inc a good long term investmentTechnology Stock Trends & Predict Volatility With Our Neural Network - earlytimes.in
Weekly Recap: How BioCardia Inc. stock reacts to bond yields2025 Major Catalysts & High Accuracy Swing Entry Alerts - BỘ NỘI VỤ
How BioCardia Inc. stock reacts to bond yieldsWeekly Market Outlook & High Accuracy Swing Trade Signals - BỘ NỘI VỤ
BioCardia appoints Farhan Shahab as VP of Quality By Investing.com - Investing.com Australia
BioCardia Appoints New VP of Quality - TipRanks
BioCardia, Inc. Appoints Farhan Shahab as Vice President of Quality - TradingView
BioCardia appoints Farhan Shahab as VP of Quality - Investing.com
BioCardia Strengthens Leadership Team with The Addition of Farhan Shahab as Vice President of Quality - The Manila Times
Will BioCardia Inc. (6JU0) stock remain on Wall Street radarJuly 2025 Trends & AI Driven Price Forecasts - newser.com
Is BioCardia Inc. stock cheap at current valuationMarket Risk Summary & Daily Profit Focused Screening - newser.com
Is BioCardia Inc. (6JU0) stock resilient in recession scenarios2025 AllTime Highs & Safe Entry Point Alerts - newser.com
Why BioCardia Inc. (6JU0) stock could be next leaderQuarterly Profit Report & Weekly Market Pulse Updates - newser.com
Is BioCardia Inc. (6JU0) stock trading at attractive multiplesWeekly Gains Report & Weekly Watchlist for Hot Stocks - newser.com
Will BioCardia Inc. stock deliver consistent dividendsMarket Activity Report & Fast Exit Strategy with Risk Control - newser.com
Biocardia Inc Stock (BCDA) Financials Data
Revenue
Net Income
Cash Flow
EPS
Biocardia Inc Stock (BCDA) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Blank Andrew Scott | Director |
Sep 19 '25 |
Buy |
1.25 |
288,000 |
360,000 |
634,023 |
| Altman Peter | President and CEO |
Sep 19 '25 |
Buy |
1.25 |
48,000 |
60,000 |
216,762 |
| Altman Peter | President and CEO |
Aug 22 '25 |
Buy |
1.83 |
700 |
1,281 |
168,762 |
| Altman Peter | President and CEO |
Aug 13 '25 |
Buy |
1.83 |
100 |
183 |
168,062 |
| Altman Peter | President and CEO |
Aug 12 '25 |
Buy |
1.75 |
400 |
700 |
167,962 |
| Altman Peter | President and CEO |
Aug 11 '25 |
Buy |
1.76 |
1,700 |
2,989 |
167,562 |
| McClung David | Chief Financial Officer |
Jun 30 '25 |
Buy |
2.08 |
4,819 |
9,999 |
47,950 |
| Altman Peter | President and CEO |
Jun 30 '25 |
Buy |
2.08 |
24,096 |
49,999 |
165,862 |
| STERTZER SIMON H | Director |
Jun 30 '25 |
Buy |
2.08 |
72,289 |
150,000 |
192,654 |
| Blank Andrew Scott | Director |
Jun 30 '25 |
Buy |
2.08 |
72,289 |
150,000 |
346,023 |
1.08%
0.91%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):